Affiliation:
1. The Shmunis School of Biomedicine and Cancer Research Tel Aviv University Tel Aviv 6997801 Israel
2. BLAVATNIK CENTER for Drug Discovery Tel Aviv University Tel Aviv 6997801 Israel
3. Department of Materials Science and Engineering Tel Aviv University Tel Aviv 6997801 Israel
Abstract
AbstractThe vital role of metabolites across all branches of life and their involvement in various disorders have been investigated for decades. Many metabolites are poorly soluble in water or in physiological buffers and tend to form supramolecular aggregates. On the other hand, in the cell, they should be preserved in a pool and be readily available for the execution of biochemical functions. We thus propose that a quality‐control network, termed “metabolostasis”, has evolved to regulate the storage and retrieval of aggregation‐prone metabolites. Such a system should control metabolite concentration, subcellular localization, supramolecular arrangement, and interaction in dynamic environments, thus enabling normal cellular physiology, healthy development, and preventing disease onset. The paradigm‐shifting concept of metabolostasis calls for a reevaluation of the traditional view of metabolite storage and dynamics in physiology and pathology and proposes unprecedented directions for therapeutic targets under conditions where metabolostasis is imbalanced.
Funder
John Templeton Foundation
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献